Among patients with drug-resistant epilepsy, frequent cannabis use may be associated with markers of increased epilepsy severity.

There is an increased risk for dementia associated with having a transient ischemic attack, underscoring the value of stroke prevention.

Dr Zayed Almadidy, MD utilizes TikTok to combat medical misinformation and educate the public about complex neuroscience topics.

Type 2 diabetes is linked to regional cortical thinning and faster cognitive decline in older adults without baseline cognitive impairment.

Inflammatory bowel disease is not associated with overall hypertensive disorders of pregnancy, but is associated with risk for preeclampsia.

Later-life depression and limited education are significantly associated with an increased risk for dementia among American Indian adults.

A machine learning model utilizing longitudinal electronic diary data can accurately forecast the likelihood of next-day migraine attacks.

Frailty is an independent risk factor for incident cognitive impairment among men with nondialysis chronic kidney disease.

FDA approves Juvmo (tavapadon), a selective D1/D5 receptor partial agonist, for Parkinson disease based on phase 3 TEMPO trial data.

FDA grants Priority Review to fenebrutinib NDA for RMS and PPMS based on phase 3 trial data showing significant relapse and progression reductions.

Most patients with atypical parkinsonism and neuronal antibodies present with additional clinical features suggestive of an autoimmune etiology.

There was relatively little difference between the leading causes of death between 2023 and 2024 in the US based on national statistics.